Predictive Technology Group (PREDQ) Aktie Kurs

Predictive Technology Group Inc is primarily active in the healthcare industry.

The main competitors of Predictive Technology Group Inc in the market include companies like Medtronic, Thermo Fisher Scientific, and Illumina.

Predictive Technology Group Inc, founded in 2017, is a cutting-edge life sciences technology company focused on genetic testing and diagnostics. Based in Salt Lake City, Utah, the company boasts a history of innovation in the field of precision medicine. Predictive Technology Group Inc has rapidly emerged as a leader in the development of advanced diagnostic tests for genetic disorders and diseases. Leveraging its proprietary molecular technologies and extensive research expertise, the company aims to revolutionize patient care and optimize treatment options through personalized medicine. With a diverse portfolio of genetic tests, Predictive Technology Group Inc continues to make significant strides in improving healthcare outcomes and enhancing quality of life for individuals worldwide.

Predictive Technology Group Inc, a leading provider of genetic testing and personalized healthcare solutions, has achieved several significant milestones. The company has successfully developed and commercialized advanced technologies in the fields of women's health, fertility, and precision medicine. It has formed strategic partnerships with renowned research institutions and healthcare providers, expanding its reach and expertise. Predictive Technology Group Inc has gained FDA clearances for its innovative genetic tests and launched groundbreaking products that empower individuals to make informed healthcare decisions. With a commitment to continuous innovation, the company is poised to further revolutionize the healthcare industry.

Predictive Technology Group Inc is primarily present in the United States.

Predictive Technology Group Inc represents values of innovation, technological advancement, and strategic partnerships. With a commitment to healthcare solutions, the company combines cutting-edge advancements in molecular diagnostics, genomics, and biotechnology to improve patient outcomes. As a leader in predictive medicine, Predictive Technology Group Inc focuses on identifying genetic markers and developing personalized therapies for various conditions. The company's corporate philosophy revolves around patient-centric care, collaboration with healthcare providers, and addressing unmet medical needs. By leveraging its expertise, Predictive Technology Group Inc aims to revolutionize healthcare through precision medicine and tailored treatments.

Omregnet til den aktuelle valutakurs handles Predictive Technology Group-aktien til 0,00 EUR (0,00 USD).

The Predictive Technology Group Inc is a company specialized in the development and application of diagnostic and therapy tools to treat health problems more precisely and effectively. The company uses innovative technologies and data analysis to make predictions and forecasts that enable doctors and patients to make informed decisions. The business model of Predictive Technology Group is divided into several divisions. The first division is Molecular Diagnostics. Here, the company develops precise tests to diagnose specific diseases. This includes tests for chronic diseases such as endometriosis, fibromyalgia, and rheumatism. In addition, the company also develops tests that can predict individual risks of diseases such as breast, ovarian, and colon cancer. The second division is Therapeutic Intervention. Here, precise diagnostics are used to develop targeted therapies. This includes personalized treatment plans based on the individual needs of the patient. The company also works on the development of new drugs and therapies to combat diseases. The third division is Healthcare Informatics. Here, the company uses data analysis to improve healthcare. To do this, it develops innovative software for data collection, analysis, and evaluation. With these tools, doctors and researchers can access real-time data to make diagnoses and optimize treatments. The company's platform also allows for the fast and effective monitoring of epidemics and infectious diseases. The company also offers a variety of products and services. These include diagnostic tests, data analysis tools, platforms for improving clinical care, and personalized treatment options. In addition, the company has also entered into a partnership with a global pharmaceutical company to jointly develop new therapies. Predictive Technology Group is focused on collaboration with other companies and institutions in the healthcare industry. The company works closely with researchers, doctors, hospitals, and pharmaceutical companies to develop and implement innovative solutions to improve healthcare. In summary, Predictive Technology Group Inc is an innovative company that relies on advanced technologies and data analysis to improve healthcare. With its precise diagnostics and personalized treatment plans, the company is working to develop solutions for some of the most pressing health problems worldwide.

Omsætningen kan for øjeblikket ikke beregnes for Predictive Technology Group.

Overskuddet kan for øjeblikket ikke beregnes for Predictive Technology Group.

P/E-forholdet kan ikke beregnes for Predictive Technology Group i øjeblikket.

P/S-forholdet kan ikke beregnes for Predictive Technology Group i øjeblikket.

AlleAktien-kvalitetsscore for Predictive Technology Group er 5/10.

ISIN for Predictive Technology Group er US74039H1023. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Predictive Technology Group er A2N4CM. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Predictive Technology Group er PREDQ. Tickersymbolet bruges til at handle Predictive Technology Group-aktier på børsen.